0001808722-20-000001.txt : 20200409
0001808722-20-000001.hdr.sgml : 20200409
20200408181208
ACCESSION NUMBER: 0001808722-20-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20200409
DATE AS OF CHANGE: 20200408
EFFECTIVENESS DATE: 20200409
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Actym Therapeutics, Inc.
CENTRAL INDEX KEY: 0001808722
IRS NUMBER: 821702886
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-364618
FILM NUMBER: 20782787
BUSINESS ADDRESS:
STREET 1: 626 BANCROFT WAY
STREET 2: SUITE A
CITY: BERKELEY
STATE: CA
ZIP: 94710
BUSINESS PHONE: 4156376691
MAIL ADDRESS:
STREET 1: 626 BANCROFT WAY
STREET 2: SUITE A
CITY: BERKELEY
STATE: CA
ZIP: 94710
D
1
primary_doc.xml
X0708
D
LIVE
0001808722
Actym Therapeutics, Inc.
626 BANCROFT WAY
SUITE A
BERKELEY
CA
CALIFORNIA
94710
4156376691
DELAWARE
None
None
Corporation
true
2017
Christopher
D
Thanos
626 Bancroft Way
Suite A
Berkeley
CA
CALIFORNIA
94710
Executive Officer
Director
Promoter
Amit
D
Kumar
626 Bancroft Way
Suite A
Berkeley
CA
CALIFORNIA
94710
Director
Promoter
Kanad
D
Das
626 Bancroft Way
Suite A
Berkeley
CA
CALIFORNIA
94710
Director
James
D
Huang
626 Bancroft Way
Suite A
Berkeley
CA
CALIFORNIA
94710
Director
Biotechnology
Decline to Disclose
- 06b
false
2020-03-27
false
true
false
0
41194276
14106048
27088228
false
28
0
0
0
false
Actym Therapeutics, Inc.
Christopher D Thanos
Christopher D Thanos
President
2020-04-08